A role for mutated blood cells in heart disease?

January 19, 2017
heart
Human heart. Credit: copyright American Heart Association

A new study provides some of the first links between relatively common mutations in the blood cells of elderly humans and atherosclerosis.

Though cardiovascular disease, which is characterized in part by atherosclerosis, or plaque build-up, is a leading cause of death in the elderly, almost 60 percent of elderly patients with (CVD) exhibit no conventional risk factors, or just one. This and other data suggest that age-dependent risk factors that haven't yet been identified may contribute to CVD.

Scientists know that accumulation of somatic DNA is a feature of aging, though little data exists on the role of such mutations in age-associated disorders beyond cancer. Meanwhile, recent human studies indicate that aging is associated with an increase in in the hematopoietic system, which gives rise to blood cells; these mutations provide a competitive growth advantage to the mutant hematopoietic cells, allowing for their clonal expansion - a process that has been shown to be associated with a greater incidence of atherosclerosis, though specifically how remains unclear.

In this study, researchers at Boston University School of Medicine (BUSM) investigated whether there is a direct relationship between such mutations and atherosclerosis. They generated an experimental model to investigate how one of the genes commonly mutated in of elderly humans, TET2, affects plaque development. Plaque formation accelerated in the models transplanted with Tet2-deficient , likely through increasing macrophage-driven inflammation in the artery wall. The results strengthen support for the hypothesis that hematopoietic mutations play a causal role in atherosclerosis.

"Our studies show that mutations in our white blood cell cells, that we acquire as we age, may cause cardiovascular disease. Understanding this new mechanism of could lead to the development of new therapies to treat individuals who suffer from heart and blood vessel ailments due to these mutations," explained corresponding author Kenneth Walsh, PhD, professor of medicine at BUSM. "Furthermore, because these mutations become prevalent starting at middle age, these studies suggest that genetic analyses of blood samples could add to the predictive value of traditional - high cholesterol, hypertension, diabetes and smoking - that are currently monitored."

The study is published in the journal Science.

Explore further: Hundreds of genetic mutations found in healthy blood of a supercentenarian

More information: "Clonal hematopoiesis associated with Tet2 deficiency accelerates atherosclerosis development in mice," Science, science.sciencemag.org/lookup/ … 1126/science.aag1381

Related Stories

Hundreds of genetic mutations found in healthy blood of a supercentenarian

April 23, 2014
Genetic mutations are commonly studied because of links to diseases such as cancer; however, little is known about mutations occurring in healthy individuals. In a study published online in Genome Research, researchers detected ...

Scientists discover gene responsible for the development of myocardial infarction

April 8, 2016
A team of Lomonosov Moscow State University scientists investigated the genetic mechanisms underlying the development of coronary atherosclerosis. The results are potentially valuable for estimating the risk of the myocardial ...

Mutations in lymphoma patients undergoing transplants raise risk of second cancers

December 5, 2016
A significant percentage of lymphoma patients undergoing transplants with their own blood stem cells carry acquired genetic mutations that increase their risks of developing second hematologic cancers and dying from other ...

How statins aid the immune system

September 21, 2016
Statins protect against cardiovascular disease in more ways than previously thought. In a study, researchers from Karolinska Institutet are able to show the immunological effects of statins, and present a new hypothesis on ...

Two new studies explore the science of cardiovascular diseases

September 27, 2016
Professor of cardiology Martin A. Schwartz led two recently published studies that advance knowledge of the underlying biology of cardiovascular diseases, which are among the most common causes of chronic illness and death ...

Recommended for you

Tiny bilirubin-filled capsules could improve survival of transplanted pancreatic cells

December 18, 2017
By encapsulating bilirubin within tiny nanoparticles, researchers from North Carolina State University and the Ohio State University have improved the survival rates of pancreatic islet cells in vitro in a low-oxygen environment. ...

Tracking effects of a food preservative on the gut microbiome

December 18, 2017
Antimicrobial compounds added to preserve food during storage are believed to be benign and non-toxic to the consumer, but there is "a critical scientific gap in understanding the potential interactions" they may have with ...

Drug found that induces apoptosis in myofibroblasts reducing fibrosis in scleroderma

December 15, 2017
(Medical Xpress)—An international team of researchers has found that the drug navitoclax can induce apoptosis (self-destruction) in myofibroblasts in mice, reducing the spread of fibrosis in scleroderma. In their paper ...

How defeating THOR could bring a hammer down on cancer

December 14, 2017
It turns out Thor, the Norse god of thunder and the Marvel superhero, has special powers when it comes to cancer too.

Researchers track muscle stem cell dynamics in response to injury and aging

December 14, 2017
A new study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) describes the biology behind why muscle stem cells respond differently to aging or injury. The findings, published in Cell Stem Cell, ...

'Human chronobiome' study informs timing of drug delivery, precision medicine approaches

December 13, 2017
Symptoms and efficacy of medications—and indeed, many aspects of the human body itself—vary by time of day. Physicians tell patients to take their statins at bedtime because the related liver enzymes are more active during ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.